Core Viewpoint - The company, Shandong Lukang Pharmaceutical Co., Ltd., is set to hold an investor briefing on September 19, 2025, to discuss its half-year financial results and address investor inquiries [2][3][4]. Group 1: Investor Briefing Details - The investor briefing will take place on September 19, 2025, from 15:00 to 16:00 [5][6]. - The event will be conducted in an interactive online format via the "Investor Relations Interactive Platform" [4][5]. - Investors can submit questions via email to lkpc_dmc@126.com before the briefing, and the company will address common concerns during the session [2][4][5]. Group 2: Company Representatives - The briefing will feature key company representatives, including Chairman Peng Xin and Financial Director Zhang Jing [4][6]. - Independent directors, including Deng Zixin, Qi Haodong, and Feng Liliang, will also be present [4]. Group 3: Post-Event Information - After the briefing, investors can access the main content and details of the event on the "Investor Relations Interactive Platform" [7].
山东鲁抗医药股份有限公司 关于召开2025年半年度业绩说明会的公告